Successful treatment of juvenile xanthogranuloma using bevacizumab

Noy Ashkenazy; Christopher R. Henry; Ashkan M. Abbey; Craig A. McKeown; Audina M. Berrocal; Timothy G. Murray

doi:10.1016/j.jaapos.2014.01.007

Successful treatment of juvenile xanthogranuloma using bevacizumab

Noy Ashkenazy, Christopher R. Henry, Ashkan M. Abbey, Craig A. McKeown, Audina M. Berrocal, Timothy G. Murray

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Abstract

Juvenile xanthogranuloma (JXG) is an uncommon non-Langerhans cell histiocytic disorder that occurs predominantly in infants. Traditional treatment of ocular JXG involves the administration of topical or local corticosteroids. We treated 2 children with JXG refractory to local corticosteroid therapy with off-label intraocular bevacizumab. To our knowledge, this is the first report of successful use of bevacizumab for ocular JXG.

Original language	English (US)
Pages (from-to)	295-297
Number of pages	3
Journal	Journal of AAPOS
Volume	18
Issue number	3
DOIs	https://doi.org/10.1016/j.jaapos.2014.01.007
State	Published - Jun 2014
Externally published	Yes

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Ophthalmology

Access to Document

10.1016/j.jaapos.2014.01.007

Cite this

@article{1d4a28daf48a4843be0121c0f38c29e6,

title = "Successful treatment of juvenile xanthogranuloma using bevacizumab",

abstract = "Juvenile xanthogranuloma (JXG) is an uncommon non-Langerhans cell histiocytic disorder that occurs predominantly in infants. Traditional treatment of ocular JXG involves the administration of topical or local corticosteroids. We treated 2 children with JXG refractory to local corticosteroid therapy with off-label intraocular bevacizumab. To our knowledge, this is the first report of successful use of bevacizumab for ocular JXG.",

author = "Noy Ashkenazy and Henry, {Christopher R.} and Abbey, {Ashkan M.} and McKeown, {Craig A.} and Berrocal, {Audina M.} and Murray, {Timothy G.}",

year = "2014",

month = jun,

doi = "10.1016/j.jaapos.2014.01.007",

language = "English (US)",

volume = "18",

pages = "295--297",

journal = "Journal of AAPOS",

issn = "1091-8531",

publisher = "Mosby Inc.",

number = "3",

}

TY - JOUR

T1 - Successful treatment of juvenile xanthogranuloma using bevacizumab

AU - Ashkenazy, Noy

AU - Henry, Christopher R.

AU - Abbey, Ashkan M.

AU - McKeown, Craig A.

AU - Berrocal, Audina M.

AU - Murray, Timothy G.

PY - 2014/6

Y1 - 2014/6

N2 - Juvenile xanthogranuloma (JXG) is an uncommon non-Langerhans cell histiocytic disorder that occurs predominantly in infants. Traditional treatment of ocular JXG involves the administration of topical or local corticosteroids. We treated 2 children with JXG refractory to local corticosteroid therapy with off-label intraocular bevacizumab. To our knowledge, this is the first report of successful use of bevacizumab for ocular JXG.

AB - Juvenile xanthogranuloma (JXG) is an uncommon non-Langerhans cell histiocytic disorder that occurs predominantly in infants. Traditional treatment of ocular JXG involves the administration of topical or local corticosteroids. We treated 2 children with JXG refractory to local corticosteroid therapy with off-label intraocular bevacizumab. To our knowledge, this is the first report of successful use of bevacizumab for ocular JXG.

UR - http://www.scopus.com/inward/record.url?scp=84902380338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902380338&partnerID=8YFLogxK

U2 - 10.1016/j.jaapos.2014.01.007

DO - 10.1016/j.jaapos.2014.01.007

M3 - Article

C2 - 24767830

AN - SCOPUS:84902380338

SN - 1091-8531

VL - 18

SP - 295

EP - 297

JO - Journal of AAPOS

JF - Journal of AAPOS

IS - 3

ER -

Successful treatment of juvenile xanthogranuloma using bevacizumab

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this